RISVAN
What it isDepot D2 and 5-HT2A antagonist risperidone; maintenance treatment of schizophrenia.
Why this oneMonthly intramuscular risperidone using in-situ-forming implant technology; no loading regimen and no oral supplementation.
What limits itProlactin elevation, parkinsonism, weight gain, and orthostasis limit use; CYP2D6 inhibitors and CYP3A4 inducers alter exposure.
⚠ BOXED WARNING

Open Risperidone LAI in the interactive console ↗
